Listar por autor "Tuñón Álvarez, Alberto"

Repositorio

Cómo publicar

Recursos

FAQs

Mostrando ítems 1-5 de 5

Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab

Villar, L.; Costa-Frossard, L.; Tuñón Álvarez, Alberto (2013)
Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A

Fernández Morera, Juan Luis; Tuñón Álvarez, Alberto; Rodríguez Rodero, Sandra; Rodrigo Sáez, Luis Ricardo; Martínez Borra, Jesús; González Rodríguez, Segundo; López Vázquez, Antonio; Hernández Lahoz, Carlos; López Larrea, Carlos (2006)
Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility

Fernández Morera, Juan Luis; Rodríguez Rodero, Sandra; Tuñón Álvarez, Alberto; Martínez Borra, Jesús; Vidal Castiñeira, José Ramón; López Vázquez, Antonio; Rodrigo Sáez, Luis Ricardo; Rodrigo Tapia, Juan Pablo; González Rodríguez, Segundo; Hernández Lahoz, Carlos; López Larrea, Carlos (2008)
Microparticles in multiple sclerosis and clinically isolated syndrome: Effect on endothelial barrier function

Marcos Ramiro, Beatriz; Oliva Nacarino, Pedro; Serrano Pertierra, Esther; Blanco Gelaz, Miguel Ángel; Weksler, Babette B.; Romero, Ignacio A.; Couraud, Piere O.; Tuñón Álvarez, Alberto; López Larrea, Carlos; Millán, Jaime; Cernuda Morollón, Eva María (2014)
Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis

Fernández Morera, Juan Luis; Rodríguez Rodero, Sandra; Hernández Lahoz, Carlos; Tuñón Álvarez, Alberto; Astudillo González, María Aurora; García Suárez, Olivia; Martínez Borra, Jesús; López Vázquez, Antonio; Rodrigo Sáez, Luis Ricardo; González Rodríguez, Segundo; López Larrea, Carlos (2008)

Listar por autor "Tuñón Álvarez, Alberto"

Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab ﻿

Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A ﻿

Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility ﻿

Microparticles in multiple sclerosis and clinically isolated syndrome: Effect on endothelial barrier function ﻿

Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis ﻿

Anti-lipid oligoclonal IgM bands contribute to progressive multifocal leukoencephalopathy (PML) risk stratification in multiple sclerosis patients treated with natalizumab

Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A

Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility

Microparticles in multiple sclerosis and clinically isolated syndrome: Effect on endothelial barrier function

Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis